Expression levels of early osteoblast marker genes SP7, RUNX2, and COL1A1 were reduced in osteoblasts from both moderate and severe patients with a G352S substitution compared to controls, except for significantly increased SP7 expression on Day 21 in the osteoblasts from the type IV OI patient. Here, RUNX2 is linked to osteogenesis imperfecta.